Prevalence of Atherosclerosis in diabetic and non-diabetic patients with rheumatoid arthritis

Bartłomiej Kisiel1, Robert Kruszewski2, Aleksandra Juszkiewicz3

  • 1Bartłomiej Kisiel, MD, PhD, Department of Internal Diseases and Rheumatology, Military Institute of Medicine, Warszawa, Poland.

Insights

Diabetic rheumatoid arthritis (RA) patients show higher rates of preclinical atherosclerosis compared to non-diabetic RA patients. Combined carotid and femoral ultrasonography did not enhance atherosclerosis detection in RA patients.

Area of Science:

  • Cardiovascular Medicine
  • Rheumatology
  • Endocrinology

Background:

  • Rheumatoid arthritis (RA) is associated with an increased risk of cardiovascular disease.
  • Diabetes mellitus further elevates cardiovascular risk.
  • The interplay between diabetes, RA, and subclinical atherosclerosis requires further investigation.

Purpose of the Study:

  • To compare the prevalence of preclinical atherosclerosis in diabetic versus non-diabetic RA patients.
  • To identify factors influencing atherosclerosis in RA.
  • To evaluate the utility of combined carotid and femoral ultrasonography for atherosclerosis detection.

Main Methods:

  • A cross-sectional study involving 42 non-diabetic RA patients, 42 diabetic RA patients, and 42 controls.
  • Measurement of intima-media thickness (IMT) in carotid and femoral arteries.
  • Screening for atherosclerotic plaque in these vessels.

Main Results:

  • Diabetic RA patients exhibited a higher prevalence of atherosclerotic plaque compared to non-diabetic RA patients and controls.
  • Elevated carotid and femoral IMT were observed in diabetic RA patients versus controls.
  • Femoral IMT was also higher in diabetic RA patients compared to non-diabetic RA patients.
  • Carotid ultrasonography alone demonstrated comparable efficacy to combined carotid and femoral ultrasonography in detecting atherosclerosis.

Conclusions:

  • Diabetic RA patients have a greater burden of subclinical atherosclerosis.
  • Combined carotid and femoral artery ultrasonography does not offer improved detection of atherosclerosis in RA patients compared to carotid ultrasonography alone.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.0K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
745
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
849
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
653
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
582
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
490